Company news

Algorae Pharmaceuticals Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

LCT files pericyte protective agent provisional patent

November 7, 2017

Appendix 4C Quarterly Cash Flow Report 30 September 2017

October 18, 2017

Preliminary Final Report and Financial Statements

August 23, 2017

NTCELL continues to halt progression of Parkinsons disease

June 6, 2017

LCT collaborates with CBR to extend product pipeline

May 16, 2017

Treatment completed for all patients in Parkinsons trial

April 30, 2017

Living Insights Newsletter February 2017

February 27, 2017

Approval granted for group 3 in Parkinsons trial

February 7, 2017

US choroid plexus cells patent application published

January 11, 2017

Group 2 Parkinsons trial patients treatment completed

December 22, 2016

Reinstatement to Official Quotation

November 29, 2016

Suspension from Official Quotation

November 27, 2016

Approval granted for group 2 in Parkinsons trial

November 10, 2016

Appendix 4C Quarterly Cash Flow Report 30 September 2016

October 19, 2016

Group 1 patients successfully treated in Parkinsons trial

October 4, 2016

LCTs joint venture focuses on US developments

August 22, 2016

NTCELL demonstrates continued reversal of Parkinsons

June 7, 2016

LCT JV secures funds to realise the potential of DIABECELL

March 30, 2016

LCT starts Phase IIb clinical trial of NTCELL

March 23, 2016

LCT completes $2.8m private placement and announces SPP

February 16, 2016

LCT receives ethics approval for Phase IIb Parkinsons trial

February 11, 2016

NTCELL reverses the progression of Parkinsons disease

February 10, 2016

← Newer news releases

Decks